FilingReader Intelligence
Huahai Pharmaceutical forecasts 40-50% profit decline for H1 2025
July 15, 2025 at 05:29 AM UTC•By FilingReader AI
Zhejiang Huahai Pharmaceutical expects net profit attributable to shareholders to fall 40-50% in the first half of 2025, ranging from 374m to 449m yuan.
The decline is attributed to intensified market competition, increased R&D investments, and unfavorable foreign exchange rate fluctuations.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Zhejiang Huahai Pharmaceutical publishes news
Free account required • Unsubscribe anytime